Ribeiro, B; Ferreira, R; Silveira, R; Fachel, Angela Aguirres; Verjovski-Almeida, Sergio 
; Vergilio, B; Albuquerque, D; Souza, C; Pagano, K
Source: Haematologica. Conference titles: Congress of the European Hematology Association. Unidade: IQ
Subjects: LEUCEMIA MIELOIDE, HEMATOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIBEIRO, B et al. Differential expression of ABCF2 in newly diagnosed and dasatinib treated chronic myeloid leukemia patients. Haematologica. Pavia: Instituto de Química, Universidade de São Paulo. . Acesso em: 16 nov. 2024. , 2015APA
Ribeiro, B., Ferreira, R., Silveira, R., Fachel, A. A., Verjovski-Almeida, S., Vergilio, B., et al. (2015). Differential expression of ABCF2 in newly diagnosed and dasatinib treated chronic myeloid leukemia patients. Haematologica. Pavia: Instituto de Química, Universidade de São Paulo.NLM
Ribeiro B, Ferreira R, Silveira R, Fachel AA, Verjovski-Almeida S, Vergilio B, Albuquerque D, Souza C, Pagano K. Differential expression of ABCF2 in newly diagnosed and dasatinib treated chronic myeloid leukemia patients. Haematologica. 2015 ; 100 685 res. PB1731.[citado 2024 nov. 16 ]Vancouver
Ribeiro B, Ferreira R, Silveira R, Fachel AA, Verjovski-Almeida S, Vergilio B, Albuquerque D, Souza C, Pagano K. Differential expression of ABCF2 in newly diagnosed and dasatinib treated chronic myeloid leukemia patients. Haematologica. 2015 ; 100 685 res. PB1731.[citado 2024 nov. 16 ]
